We discovered that the reduced viability of FLT3-ITD and FLT3-ITD(D835Y) MOLM14 cells in the current presence of NCGC1481 was because of increased apoptosis (Body 2B). Open in another window Figure 2 NCGC1481 goals relevant FLT3-mutant AML cells in vitro clinically.(A) Viability of MOLM14-FLT3-ITD and MOLM14-FLT3-ITD(D835Y) cells treated using the indicated inhibitors for 72 hours. midostaurin, […]